Patent Number: 6,169,105

Title: Potentiation of drug response

Abstract: The power of citalopram, fluvoxamine and paroxetine to increase the availability of sarotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.

Inventors: Wong; David Taiwai (Indianapolis, IN), Oguiza; Juan Ignacio (Madrid, ES)

Assignee: Eli Lilly and Company

International Classification: A61K 45/00 (20060101); A61K 31/135 (20060101); A61K 45/06 (20060101); A61K 31/15 (20060101); A61K 31/40 (20060101); A61K 31/403 (20060101); A61K 31/34 (20060101); A61K 31/38 (20060101); A61K 31/405 (20060101); A61K 31/445 (20060101); A61K 31/495 (20060101); A01N 043/38 ()

Expiration Date: 01/02/2018